Abstract
Although the adverse event rates reported for peroral endoscopic myotomy (POEM) for treatment of achalasia have been amazingly low, consensus recommendations do not support its use as first-line therapy in elderly patients. In one previous report, more than 60% of patients aged ≥75 years with achalasia were left untreated, presumably because of high perceived risk for procedure-related adverse events. To investigate the …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
